Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Just Reported Yearly Earnings: Have...

Published on 15 Feb 2025 on Simply Wall St. · via Yahoo Finance

Last week, you might have seen that Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) released its yearly...

Read the rest of the article

Start tracking your investments with Statfolio

Last week, you might have seen that Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) released its yea...

Simply Wall St. · via Yahoo Finance 15 Feb 2025

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 17 Jan 2025

In conjunction with the 2025 J.P. Morgan Healthcare Conference, the analyst hosted an investor lu...

Benzinga · via Yahoo Finance 15 Jan 2025

Ultragenyx Pharmaceutical Inc (RARE) reports a 42% year-over-year revenue increase, driven by str...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarte...

Insider Monkey · via Yahoo Finance 1 Nov 2024

We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article,...

Insider Monkey · via Yahoo Finance 21 Aug 2024

Key Insights Ultragenyx Pharmaceutical will host its Annual General Meeting on 18th of JuneCEO Em...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

Ultragenyx Pharmaceutical RARE announced positive top-line results from the late-stage study of i...

Zacks via Yahoo Finance 31 May 2024

Total Revenue: Reported $109 million in Q1 2024, an 8% increase year-over-year, falling short of ...

GuruFocus.com via Yahoo Finance 5 May 2024

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) just released its latest first-quarter report and th...

Simply Wall St. via Yahoo Finance 4 May 2024